Several mechanisms have been proposed to explain steroid resistance in T-ALL including activation of AKT1, which phosphorylates serine 134 of NR3C1, thereby preventing nuclear translocation [13]. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.